About
ProCore Bio Med is a biotechnology company developing cost-effective solutions with a focus on bone and cartilage regeneration, integrating proprietary scaffolds, growth factors, and stem or progenitor cells. The companys technology platform includes a variety of biomaterials useful for multiple clinical applications, in particular hyaluronic acid-based injectable hydrogels; a set of proprietary growth factors with enhanced activity, selectivity, and stability; and protocols for stem and progenitor cell isolation, expansion, and differentiation. ProCores RegenoGel is a highly stable viscosupplement gel for treating osteoarthritis to preserve joints and regenerate cartilage. RegenoGel is based on the companys proprietary HAProLink, which joins a high-molecular-weight HA with a regenerative fibrinogen matrix. ProCore has been a principal member of the Genesis consortium, the Israeli consortium for stem cell therapy. Procore was acknowledged for its contributions to the consortium, including allowing access to its proprietary set of FGF variants, as well as for its unique stem cell platform and the development of a novel antibody microarray for stem cell characterization.
Q&A
- What is ProCore Bio Med's primary focus?
- ProCore Bio Med is a biotechnology company focused on developing cost-effective solutions for bone and cartilage regeneration, utilizing proprietary scaffolds, growth factors, and stem or progenitor cells.
- What is ProCore Bio Med's flagship product for osteoarthritis?
- ProCore Bio Med's flagship product is RegenoGel, a highly stable viscosupplement gel designed to treat osteoarthritis by preserving joints and regenerating cartilage. It is based on the company's proprietary HAProLink technology.
- What kind of technology platform does ProCore Bio Med utilize?
- ProCore Bio Med's technology platform includes various biomaterials, such as hyaluronic acid-based injectable hydrogels, proprietary growth factors with enhanced activity, and protocols for stem and progenitor cell isolation, expansion, and differentiation.
- When was ProCore Bio Med founded?
- ProCore Bio Med was founded in September 2008.
- Where is ProCore Bio Med headquartered?
- ProCore Bio Med is headquartered in Ness Ziona, Center District, Israel.
- What is the employee count for ProCore Bio Med?
- ProCore Bio Med has 1-10 employees.
- Who is the Founder and CEO of ProCore Bio Med?
- Prof. Avner Yayon is the Founder and CEO of ProCore Bio Med.
- Has ProCore Bio Med been involved in any consortiums?
- Yes, ProCore Bio Med has been a principal member of the Genesis consortium, the Israeli consortium for stem cell therapy.
- What is the current product stage of ProCore Bio Med?
- ProCore Bio Med's product is currently released.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | regenogel.co.il/ |
|---|---|
| facebook.com/RegenoGelProcore |
Identifiers & details
| Founded | 2008-9 |
|---|---|
| Employees (exact) | 6 |
Radar intelligence
Web history (Wayback)
| Domain | regenogel.co.il |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|